Endothelial dysfunction in chronic obstructive pulmonary diseases
Abstract
Endothelial dysfunction is considered as one of the links between pulmonary and cardiovascular diseases. To evaluate the dynamics of endothelial function in patients with dyslipidemia and chronic obstructive pulmonary diseases, receiving atorvastatin.
About the Authors
M. V. Sholkava
Belarusian State Medical University
Belarus
Belarus
E. A. Dotsenko
Belarusian State Medical University
Belarus
Belarus
References
1. Guerra S. Asthma and chronic obstructive pulmonary disease. Curr Opin Allergy Clin Immunol, 2009, vol. 9, no. 5, рр. 409–416.
2. Diagnosis of Diseases of Chronic Airflow Limitation: Asthma, COPD and Asthma-COPD Overlap Syndrome (ACOS) [electronic resource]. Global Strаtegy for Asthma Management and Prevention, 2014. Available at: https://goldcopd.org/asthma-copd-asthma-copdoverlap-syndrome. (accessed 11.09.2017).
3. Rothnie K.J., Yan R., Smeeth L., Quint J.K. Risk of myocardial infarction (MI) and death following MI in people with chronic obstructive pulmonary disease (COPD): a systematic review and meta-analysis [electronic resource]. BMJ Open, 2015, vol. 5, no. 9, e007824. Available at: https://www.ncbi.nlm.nih.gov/pubmed/26362660. (accessed 11.03.2018).
4. Tattersall M.C., Guo M., Korcarz C.E., Gepner A.D., Kaufman J.D., Liu K.J., Barr R.G., Donohue K.M., McClelland R.L., Delaney J.A., Stein J.H. Asthma predicts cardiovascular disease events: the multi-ethnic study of atherosclerosis. Arterioscler Thromb Vasc Biol, 2015, vol. 35, no. 6, pp. 1520–1525.
5. Khaddaj M.R., Mathew J.C, Kendrick D.J., Braun A.P. The vascular endothelium: A regulator of arterial tone and interface for the immune system. Crit Rev Clin Lab Sci, 2017, vol. 54, no. 7-8, pp. 458–470.
6. Maruhashi T., Soga J., Fujimura N., Idei N., Mikami S., Iwamoto Y., Kajikawa M., Matsumoto T., Hidaka T., Kihara Y., Chayama K., Noma K., Nakashima A., Goto C., Tomiyama H., Takase B., Yamashina A., Higashi Y. Relationship between flow-mediated vasodilation and cardiovascular risk factors in a large community-based study. Heart, 2013, vol. 99, no. 24, pp. 1837–1842.
7. Goldenberg N.M., Kuebler W.M. Endothelial cell regulation of pulmonary vascular tone, inflammation, and coagulation. Compr Physiol, 2015, vol. 5, no. 2, pp. 531–559.
8. Ambrosino P., Lupoli R., Iervolino S., De Felice A., Pappone N., Storino A., Di Minno M.N.D. Clinical assessment of endothelial function in patients with chronic obstructive pulmonary disease: a systematic review with meta-analysis. Intern Emerg Med, 2017, vol. 12, no. 6, pp. 877–885.
9. Dang H., Song B., Dong R., Zhang H. Atorvastatin reverses the dysfunction of human umbilical vein endothelial cells induced by angiotensin II. Exp Ther Med, 2018, vol. 16, no. 6, pp. 5286–5297.
10. Oesterle A., Laufs U., Liao J.K. Pleiotropic Effects of Statins on the Cardiovascular System. Circ Res, 2017, vol. 120, no. 1, pp. 229–243.
11. Margaritis M., Channon K.M., Antoniades C. Statins as regulators of redox state in the vascular endothelium: beyond lipid lowering. Antioxid Redox Signal, 2014, vol. 20, no. 8, pp. 1198–1215.
12. Zhang L., Gong D., Li S., Zhou X. Meta-analysis of the effects of statin therapy on endothelial function in patients with diabetes mellitus. Atherosclerosis, 2012, vol. 223, no. 1, pp.78–85.
13. Chen J.H., Wu T., Yang L.K., Chen L., Zhu J., Li P.P., Hu X., Wang Y.H. Protective effects of atorvastatin on cerebral vessel autoregulation in an experimental rabbit model of subarachnoid hemorrhage. Mol Med Rep, 2018, vol. 17, no. 1, pp. 1651–1659.
14. Lo C.C.W., Moosavi S.M., Bubb K.J. The Regulation of Pulmonary Vascular Tone by Neuropeptides and the Implications for Pulmonary Hypertension. Front Physiol. 2018, vol. 23, no. 9, pp. 1167. doi: 10.3389/fphys.2018.01167.
Review
For citations:
Sholkava M.V., Dotsenko E.A. Endothelial dysfunction in chronic obstructive pulmonary diseases. Emergency Cardiology and Cardiovascular Risks journal. 2019;3(1):539-545. (In Russ.)
Views:
20
Email this article 